This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
MEDBOX Issue Brief no. 19: World TB Day: Invest to end TB. Save Lives
Updated Treatment Guidelines
Reviewed Essential Medicines List July 2021
Milestones in the treatment, care and support, Dec 2021
Results of an innovative model launched in TB clinics in six regions
Accessed: 12.03.2020
Advance Copy
Accessed: 08.03.2020
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis ...B and/ or hepatitis C are unware of their infection and do not benefit from promotive, preventive and curative services designed to reduce onward transmission. Zambia introduced hepatitis B virus vaccine to the routine Under 5 vaccination schedule in 2005. Preliminary results from the ZAMPHIA indicate that hundreds of infections have been abated in children since then. However, its also clear that we continue to miss key opportunities to prevent transmission, diagnose and treat infections, prevent serious disease, and in many cases cure people. In addition, high risk groups inter alia health care workers still have limited access to the vaccine.
more
Version 3.0
Accessed: 24.11.2019
Policy Brief
Accessed: 20.11.2019
Summary Report
Accessed: 19.10.2019
Accessed: 08.10.2019
Based on the National Guidelines for the Management of Tuberculosis in Children 2013, Department of Health, South Africa.
Zero new HIV infections
Zero Discrimination
Zero AIDS related deaths
Accessed: 04.10.2019